Colloquium on the Cytoskeleton and Human Disease

描述(由申请人提供)： 一次广泛关注的细胞骨架及其相关的国际研究会议 人类疾病中的相关蛋白质计划从4月17日到4月 20,2001年。这次会议的题目是细胞骨架与人类的座谈会 疾病，将在大学医学院/药学院校园举行 在地中海，特别是在Faculte de Medicie，这是 位于马赛市中心。我们预计大约有150人参加 包括研究生和博士后研究员。事情已经很清楚了 主要的细胞骨架成分，微管，中间丝， 和肌动蛋白细丝，都与多种人类疾病有关。 因此，我们的目的是召集科学家参与第一次 关于细胞骨架及其相关蛋白的广泛研究会议 在人类疾病中。与细胞骨架相关的新药和新靶点 它的相关蛋白质将被突出显示。这次会议将包括以下内容 受邀的讲座、简短的口头交流和海报会议。要讨论的主题 涵盖的内容包括：1)微管与癌症(微管靶向 抗癌药物、抗药性、新方法和新化合物)， 2)微管相关蛋白与神经退行性疾病(阿尔茨海默病 疾病和其他自发性疾病、新概念和新靶点)，3)中间 细丝和疾病(角蛋白和皮肤病，骨骼和皮肤中的结蛋白 心肌疾病、肌营养不良症)，以及4)微丝和疾病 ()细胞黏附、迁移、转移、传染病、膜肌 缺陷、潜在的新目标)。来自北京的组委会成员 美国有莱斯利·威尔逊博士、玛丽·安·乔丹博士、欧内斯特·布拉格博士、 文森特·佩罗和伯纳德·罗西诺。威尔逊博士，布莱恩德博士，乔丹博士，哈默尔博士， Marvaldi和Binder对科学研究负有主要责任 项目，以及布赖恩德、威尔逊、布赖恩德、威尔逊、布拉格、佩罗和 Rossignol负责会议安排。

DESCRIPTION (provided by applicant): A broadly focused international research meeting on the cytoskeleton and its associated proteins in human diseases is planned from April 17 through April 20, 2001. The meeting, entitled Colloquium on the Cytoskeleton and Human Disease, will be held on the medical/pharmacy school campus of the University of the Mediterranean, specifically at the Faculte de Pharmacie, which is located in the center of Marseille. We expect approximately 150 participants including graduate students and post doctoral fellows. It has become clear that the major cytoskeletal components, microtubules, intermediate filaments, and actin filaments, are involved in a large number of diverse human diseases. Thus our purpose is to assemble scientists to participate in the first broadly-based research meeting on the cytoskeleton and its associated proteins in human disease. New drugs and new targets related to the cytoskeleton and its associated proteins will be highlighted. The meeting will consist of invited lectures, short oral communications, and poster sessions. Topics to be covered include: 1)microtubules and cancer (microtubule-targeted anticancer drugs, drug resistance, new approaches and new compounds), 2)microtubule-associated proteins and neurodegenerative disease (Alzheimer's disease and other tauopathies, new concepts and new targets), 3)intermediate filaments and disease (keratin and skin diseases, desmin in skeletal and cardiac muscle disease, muscular dystrophy), and 4)microfilaments and disease ()cell adhesion, migration metastasis, infectious diseases, membrane muscle defects, potential new targets). The members of the organizing committee from the United States are Drs. Leslie Wilson, Mary Ann Jordan, Ernest Braguer, Vincent Peyrot, and Bernard Rossignol. Drs. Wilson, Briand, Jordan, Hamel, Marvaldi, and Binder have the primary responsibility for the scientific program, and Drs. Briand, Wilson, Briand, Wilson, Braguer, Peyrot, and Rossignol are in charge of meeting arrangements.